1. TAK1 signaling is a potential therapeutic target for pathological angiogenesis
   Linxin Zhu et al, 2021, Angiogenesis CrossRef
2. NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivo
   Qizhao Ma et al, 2019, Apoptosis CrossRef
3. Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
   Paul M. Panipinto et al, 2021, International Journal of Molecular Sciences CrossRef